South Pharmaceutical is a leading producer of paclitaxel and its intermediates in the Chinese pharmaceutical industry. It is the developer of the national standard "Technical Regulations for the Cultivation of Taxus mairei and Paclitaxel Raw Material Forests in the South," and one of the largest planting bases for Taxus mairei and production bases for paclitaxel and its intermediates in China. The company emphasizes technological innovation and the construction of its research and development team, holding 8 PCT international invention patents and 23 Chinese invention patents.
South Pharmaceutical has a strong sense of social responsibility, focusing on environmental protection and green development. It has a comprehensive environmental management and occupational health and safety management system (EHS system).
福建(jian)南(nan)(nan)方制藥股份有限公(gong)司(證(zheng)券代(dai)碼:831207)成(cheng)立于(yu)2001年(nian)9月,致力于(yu)以紫杉醇(chun)原料藥為代(dai)表的(de)抗腫瘤藥物的(de)研發和生(sheng)產,是(shi)一家集藥物種植、研發、生(sheng)產、銷(xiao)售于(yu)一體的(de)GMP制藥企業。公(gong)司旗下雪峰(feng)、瀚仙兩個(ge)廠(chang)區占地面積共13.1萬平方米(mi),擁有4000畝優選南(nan)(nan)方紅豆杉種植基地。
南方(fang)制藥(yao)是(shi)中(zhong)(zhong)國(guo)制藥(yao)行業領(ling)先的(de)(de)紫(zi)(zi)杉烷類(lei)原料(liao)藥(yao)及中(zhong)(zhong)間體(ti)產品(pin)生(sheng)產企業,是(shi)國(guo)家標準(zhun)《南方(fang)紅豆杉紫(zi)(zi)杉醇原料(liao)林豐(feng)產栽培技術規程》的(de)(de)制定者,是(shi)中(zhong)(zhong)國(guo)最大(da)的(de)(de)紅豆杉種植基(ji)地(di)(di)和紫(zi)(zi)杉烷類(lei)產品(pin)生(sheng)產供應基(ji)地(di)(di)之一。公司(si)重視技術革新(xin)和研發(fa)隊(dui)伍的(de)(de)建設,現有(you)8項PCT國(guo)際發(fa)明(ming)專利(li)、23項中(zhong)(zhong)國(guo)發(fa)明(ming)專利(li)。
南(nan)方制藥富有(you)良好的(de)(de)社會責(ze)任感,致力于(yu)環境保護(hu)和綠色(se)發(fa)展,擁有(you)完備的(de)(de)環境管理和職業健康安全管理體系(EHS體系)。
Fujian South Pharmaceutical Co., Ltd. (Stock Code: 831207) was established in September 2001. It is committed to the research and production of anti-tumor drugs, with paclitaxel as its representative, and is a GMP pharmaceutical enterprise integrating drug planting, research, production, and sales. The company's two factory areas, Xuefeng and Hanxian, cover a total area of 131,000 square meters and have a 4,000-acre high-quality southern yew planting base.
通過(guo)國家藥品GMP認證(zheng)
Obtained National Drug GMP Certification
首(shou)次通過國家(jia)高(gao)技術企業(ye)資格認證
First-time accreditation as a National High-Tech Enterprise
旗(qi)下南方制藥(yao)公司(si)新(xin)三板上市(證券代碼:831207)
South Pharmaceutical Company, a subsidiary, listed on the New Third Board (Securities Code: 831207)
通過美(mei)國(guo)FDA現場審計
Passed on-site audit by the U.S. Food and Drug Administration (FDA)
榮獲高新(xin)技(ji)術企(qi)業、國家林業重(zhong)點龍(long)頭(tou)企(qi)業等稱號
Honored with titles such as High-Tech Enterprise and National Forestry Key Leading Enterprise
通過歐(ou)盟(meng)EDQM藥(yao)品(pin)質量認證
Passed the European Directorate for the Quality of Medicines & HealthCare (EDQM) certification for drug quality
榮獲(huo)國家專精特新“小巨(ju)人”企業稱(cheng)號(hao)
2021: Awarded the title of "National Specialized and Innovative 'Small Giant' Enterprise"
與上海熙(xi)華(hua)藥(yao)業合作,投資(zi)「福建熙(xi)華(hua)醫藥(yao)產業園」
Cooperated with Shanghai Xihua Pharmaceutical Industry to invest in the 「Fujian Xihua Pharmaceutical Industrial Park」